All Instruments

RSD-RS

Active

Rejection Sensitivity Dysphoria Rating Scale

A 55-item instrument measuring rejection sensitivity across 6 vulnerability domains plus 12 protective factor subscales (24 items). The most publication-ready instrument in the PandaScales suite, with clear psychometric properties and established scoring.

Vulnerability Items

30

Protective Items

24 + 1

Domains

6 + 12 PF

Response Scale

0–4

Vulnerability Domains

Six domains capturing the full RSD experience, from trigger to functional impact. 5 items each, 30 items total.

Domain A

Trigger Sensitivity

Sensitivity to criticism, perceived rejection, and disapproval from others.

5 items

Domain B

Dysphoric Pain & Shame

Emotional pain, shame, worthlessness, and the intensity of the rejection experience.

5 items

Domain C

Anticipatory Hypervigilance

Monitoring others for signs of rejection, worry about upcoming interactions, and anticipatory anxiety.

5 items

Domain D

Acute Reactivity

Withdrawal, anger, tearfulness, cognitive flooding, and immediate behavioural responses to perceived rejection.

5 items

Domain E

Recovery & Aftermath

Rumination, reassurance-seeking, perfectionism as prevention, avoidance, and emotional recovery time.

5 items

Domain F

Functional Impact

Relationship impact, avoidance of opportunities, performance effects, help-seeking barriers, and daily life interference.

5 items

Protective Factor Profile

12 protective factors, each measured by 2 items (24 items total) plus 1 supplementary perfectionism item. These capture the individual's resilience resources.

S1

Self-Compassion

S2

Rejection Resistance

S3

Cognitive Flexibility

S4

Autonomy Preservation

S5

Healthy Assertion

S6

Recovery Capacity

S7

Mentalizing Balance

S8

Values Clarity

S9

Support Seeking

S10

Distress Tolerance

S11

Imperfection Tolerance

S12

Somatic Awareness

Instrument Variants

Multiple administration forms for different clinical contexts.

RSD-RS-10

Free Screener

10 items

Brief screening version for initial identification.

RSD-RS-55

Full Assessment

55 items

Complete assessment with 6 vulnerability domains and 12 protective factors.

RSD-RS-55-F

Follow-Up

55 items

Repeat administration for tracking change over time.

RSD-RS-55-D

Discharge

55 items

End-of-intervention assessment for measuring treatment outcomes.

Age Versions

Adult

Ages 18+

Primary self-report version with full clinical language.

Adolescent

Ages 12–17

Age-adapted wording for adolescent self-report.

Child

Ages 6–11

Simplified language for child self-report or parent/carer completion.

Sample Items

Representative items from vulnerability domains and protective factors.

Domain A

I notice even small changes in how people respond to me and immediately worry I have done something wrong.

Domain B

When I feel rejected, the emotional pain feels physical — like a punch to the chest.

Domain D

When I feel criticised, I either withdraw completely or respond with sudden anger.

Domain S1

I can remind myself that my worth does not depend on one person's opinion.

Domain S6

After a rejection experience, I can usually recover within a reasonable timeframe.

Scoring & Interpretation

Response Scale

5-point scale: Not at all (0), Rarely (1), Sometimes (2), Often (3), Almost always (4)

Severity Bands

Minimal, Mild, Moderate, Severe, Extreme — derived from percentage scores.

Protective Factor Profile

12 protective factors scored independently, identifying resilience resources and development targets.

Clinical Flags

Automated flags for high vulnerability with low protective factors and domain-specific risk patterns.

Outputs

Domain Scores

Raw and percentage scores for all 6 vulnerability domains.

Severity Bands

Per-domain severity from Minimal to Extreme.

Protective Factor Profile

12 protective factors with individual scores and overall resilience index.

Full Assessment Report

Comprehensive PDF with all scores, interpretations, and clinical recommendations.

Use the RSD-RS

The most publication-ready instrument in the PandaScales suite. Contact us for licensing or research collaboration.